Clinical Trial Update: Once-a-day Tacrolimus Conversion Study: The OneTAC Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the OneTAC Trial evaluating once-daily tacrolimus conversion, sponsored by Newark Beth Israel Medical Center for heart failure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Newark Beth Israel Medical Center | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN